AF
VYGR icon

Allworth Financial’s Voyager Therapeutics VYGR Stock Holding History

Allworth Financial’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.54K Buy
440
+143
+48% +$542 ﹤0.01% 4598
2026
Q1 		$1.15K Buy
297
+133
+81% +$524 ﹤0.01% 4528
2025
Q4 		$645 Hold
164
– – ﹤0.01% 4471
2025
Q3 		$766 Buy
164
+153
+1,391% +$554 ﹤0.01% 4327
2025
Q2 		$35 Hold
11
– – ﹤0.01% 4482
2025
Q1 		$39 Sell
11
-40
-78% -$187 ﹤0.01% 3985
2024
Q4 		$277 Buy
+51
New +$329 ﹤0.01% 3728

Other funds holding VYGR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Allworth Financial's VYGR Position: Q2 2026 in Review

Allworth Financial increased its Voyager Therapeutics (VYGR) stake by 48% in Q2 2026, buying an estimated $542 and bringing the position to 440 shares worth $1.54K. The position accounts for ﹤0.01% of the portfolio, ranked #4598.

Allworth Financial first reported a position in VYGR in Q4 2024 and has held it in 7 quarters since. 136 funds tracked by Wall St. Rank hold VYGR as of Q2 2026.

  • Allworth Financial held 440 shares of Voyager Therapeutics worth $1.54K as of Q2 2026.
  • Allworth Financial bought 143 Voyager Therapeutics shares in Q2 2026, an estimated $542.
  • Voyager Therapeutics made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #4598 holding.
  • Allworth Financial first reported a position in Voyager Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • 136 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.